A group of more than 200 picketers concerned about an ongoing assault by the pharmaceutical industry on a drug price discount program utilized by many non-profit hospitals and community clinics to help them provide medical care and services to low-income individuals and underserved populations, are expected at a robust demonstration and picket line
Contract notice: active substance dexamethasone intravitreales implant,. the dak-g assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory accessibility of all pharmaceutical companies. Prerequisites for the conclusion or subsequent accession to the contract
Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $32.00 per share, for gross proceeds of $176 million before deducting estimated underwriting
Both Anderson and Greenville counties are considering similar action. The Greenville News reports Greenville County Council hired Spartanburg attorney John White Tuesday to investigate the grounds for filing its own suit over the crisis. In Anderson, the Independent Mail reports County Council chairman Tommy Dunn encouraged his colleagues to take..
Albany, NY 02/21/2018 Medical imaging is used to define the use of conventional and sophisticated diagnostic practices. Traditional imaging techniques like computed tomography, magnetic resonance imaging, ultrasound, X-ray, and nuclear medicine usually analyze morphology and anatomy but are unable to detect changes at the molecular level.
Nektar Therapeutics will announce its financial results for the fourth quarter and year-ended December 31, 2017, on Thursday, March 1, 2018, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/ 2:00 p.m. Pacific
Feb. 21 The city of Portland will join a national movement by suing drug companies behind America's opioid crisis. "This is a much-needed step to help stem the tide of opioid addiction in our community," Portland Mayor Ted Wheeler said. Portland will join at least 370 other cities and counties across America suing drug manufacturers or distribut
Electronic auction: purchase of vaccines used in veterinary medicine. Vaccine anti-rabies inactivated culture liquid against rabies animals or its analogue. End date for receipt of proposals: 12.03. 2018 Major organization: ESTABLISHMENT "YELSK DISTRICT VETERINARY STATION" Address: 247873 Gomel Region, The City Of Yeltsin Kochishchansky Tract, 3 At
Albany, NY 02/21/2018 Single-use or disposable products or technology is intended to be used for one time only and then are meant for disposing. These technologies are mainly made from Plastic which are disposed off after use. Single-use technologies have transformed the field of biopharmaceuticals.
By a News Reporter-Staff News Editor at Telecommunications Weekly A patent application by the inventors Carrender, Curtis L.; Morrisey, Daniel; Sainion, Soneer, filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent applicati
"It's the first service of its kind to aid pharmaceutical companies in this way," described Stephen Braddock, MD, a St. Louis- based pediatrician and dysmorphologist in reference to a new endeavor offered by birth defects experts at the Organization of Teratology Information Specialists. OTIS, Inc. is a wholly owned Benefit Corporation established
The "Drug Analysis: Dengue DNA vaccine" drug pipelines has been added to ResearchAndMarkets.com' s offering. The US Naval Medical Research Center is developing a Vaxfectin- adjuvanted, tetravalent plasmid DNA vaccine. In 2008, Vical entered into an agreement with the NMRC to manufacture the vaccine, but it does not currently have a license for furt
Tenders are invited for 2018/ 011542. supply of exclusive medicines from the pharmaceutical company eisai, s.A., for the health logistics platform of almera. Budget base for tender: 566,937.93 euros Estimated value of the contract: 1,303,957.25 euros Type of contract: supplies Place of execution: spain- almera. End date for submission of offer: 06/
Cyclacel announced a notice of grant of new European patent covering sapacitabine pharmaceutical formulations. Kirkland Lake Gold Ltd. rose 5.7 percent to $15.00 in pre-market trading following Q4 results. Franklin Electric Co. rose 5.3 percent to $41.95 in pre-market trading after dropping 10.35 percent on Tuesday. LivePerson, Inc. shares rose 5..
Pharmaceutical companies are the base for managing life threatening ailments and without them the healthcare sector wouldn t be as sophisticated as it is today.. Are You Aware of the FDA's Plans for 2018? All numbers and figures are current as of 1:30 p.m. EST, February 20, 2018.
NORTH CHICAGO- AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and..
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer`s disease and other...
AbbVie, a global research and development-based biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc., announced that the Phase 3 ELARIS UF-I study of elagolix met its primary endpoint. Uterine fibroids are the most common type of abnormal growth in a woman's pelvis and can affect up to 80 percent of women by age 50. 1 Fibro
AbbVie has teamed up with Voyager Therapeutics on a tau protein-targeting program, paying $69 million upfront for an option on the Alzheimers disease candidate. According to AbbVie, that approach would have dosing advantages over current tau-targeting drugs in the industrys pipeline that could translate into a higher chance of showing efficacy.
AbbVie will partner with Voyager Therapeutics to develop and commercialize gene therapies for Alzheimer`s disease and other neurodegenerative diseases, through a collaboration that could generate more than $1.1 billion- plus for Voyager, the companies said today. Voyager`s vectorized antibody platform presents an innovative approach to addressing..
NEW YORK and CLEVELAND, Feb. 21, 2018 Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the Company s senior management team will participate in the following investor and industry conferences..
BARCELONA, Catalonia, Spain- Ability Pharmaceuticals SL, a biopharmaceutical company announced today that the United States Food and Drug Administration has approved a phase 1/ 2 study to assess the efficacy and safety of ABTL0812 in combination with gemcitabine and nab-paclitaxel in patients with advanced metastatic pancreatic cancer at first line
SAN DIEGO- ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2017 on Tuesday, February 27,
CAMBRIDGE, Mass.- Acceleron Pharma Inc. today announced it will host a webcast and conference call on Tuesday, February 27, 2018 at 5:00 p.m. EST to discuss its fourth quarter and full year 2017 operating and financial results. Acceleron is a Cambridge- based, clinical-stage biopharmaceutical company dedicated to the discovery, development, and...